Pharming Group N.V.
PHAR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828316
No open-market purchases or sales by Pharming Group N.V. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $1.31M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Pharming Group N.V. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 5 | 4 | −1 |
| Shares | 51.1K | 51.9K | +772 (+1.5%) |
| Value | $514.3K | $434.0K | −$80.4K (−15.6%) |
New holders (2)
Institutions that held Pharming Group N.V. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nalls Sherbakoff Group, LLC | 870 | $7.28K | 0.01% |
| Coldstream Capital Management Inc | 106 | $887 | 0.00% |
Sold out (3)
Institutions that held Pharming Group N.V. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Advisor Group Holdings, Inc. | 483 | $4.86K |
| Farther Finance Advisors, LLC | 11 | $111 |
| UBS Group AG | 10 | $101 |